March 29, 2017 5:32 AM ET

Biotechnology

Company Overview of MAB Discovery GmbH

Company Overview

MAB Discovery GmbH discovers and develops monoclonal antibody therapeutics. The company has a strategic alliance with BioDuro Biologics. MAB Discovery GmbH was founded in 2010 and is based in Neuried, Germany.

Forstenrieder Strasse 8-14

Neuried,  82061

Germany

Founded in 2010

Phone:

49 89 990 1780

Fax:

49 89 990 178199

Key Executives for MAB Discovery GmbH

MAB Discovery GmbH does not have any Key Executives recorded.

MAB Discovery GmbH Key Developments

MAB Discovery GmbH Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 through Mar-07-2017

MAB Discovery GmbH Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 through Mar-07-2017. Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Presentation Date & Speakers: Mar-06-2017, Michael Motz, CEO.

Fusion Antibodies and MAB Discovery to Collaborate on the Development of Fully Humanized Antibodies

Fusion Antibodies and MAB Discovery announced their intention to enter into a research and licence agreement in the field of monoclonal antibodies. Within the scope of this collaboration, Fusion Antibodies will apply its proprietary CDRx(TM) Multiplex platform to humanize therapeutic antibodies selected and produced by MAB Discovery. MAB Discovery will provide high-quality humanized antibodies ready for further development to potential partners.

Sanofi Enters into Research and License Agreement with MAB Discovery GmbH

Sanofi has entered into a research and license agreement with MAB Discovery GmbH in the field of monoclonal antibodies. Under the terms of the transaction, MAB Discovery will develop therapeutic antibodies for selected targets of Sanofi and thus support Sanofi in the development of antibody-based therapies. Sanofi will in return receive antibodies with the aim of identifying active substances for a number of diseases that are difficult to treat. When specific milestones are achieved, the agreement provides for further performance-related payments to MAB Discovery.

Similar Private Companies By Industry

Company Name Region
µ-bond GmbH Europe
4 Animals AlsterScience GmbH Europe
Acousia Therapeutics GmbH Europe
Across Barriers GmbH Europe
Actinodrug Pharmaceuticals GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MAB Discovery GmbH, please visit www.mabdiscovery.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.